RxDoctor Payments Data

Jeanne Sparks, PA

Dermatology · Sparks, MDNPI 1932486644

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.2% of the total across 637 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,372, more than ten times the $40 reported in 2019.

$10,155in general payments, 2019–2025

Across 637 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • AbbVie$2K
  • Novartis$1K
  • Regeneron Healthcare Solutions, Inc.$771
  • Sun Pharmaceutical Industries Inc.$611
  • Pfizer$546
  • plus $4K from 24 others

What the payments were for

  • Consulting fees$2502%
  • Food & beverage$9,36792%
  • Education$5375%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,155 in reported general payments places this provider in the 80th percentile of 306 dermatology providers in Maryland.

See all dermatology providers in Maryland

Medicare billing

Part B allowed, 2024
$180,926
Medicare patients
798
Services billed
3,085

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate108$4,525
Ketoconazole173$2,834
Fluorouracil40$2,282
Triamcinolone Acetonide136$2,108
Doxycycline Hyclate68$1,575
Gentamicin Sulfate39$1,485
Metronidazole29$1,240
Clindamycin Phosphate26$797
ValacyclovirValacyclovir Hcl32$663
Betamethasone Dipropionate15$507
Nystatin41$422
Hydrocortisone91$411
Methylprednisolone23$145
Cephalexin13$117
CiclopiroxCiclopirox Olamine11$113

Paid to pharmacies, not to this prescriber.

Other dermatology in Sparks

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →